Congenital and acquired brain injury. 4. New frontiers: Neuroimaging, neuroprotective agents, cognitive-enhancing agents, new technology, and complementary medicine

Archives of Physical Medicine and Rehabilitation

Volumn 84, Issue 3, 2003, Pages

  McElligott, Jacinta M ^a   Greenwald, Brian D ^b   Watanabe, Thomas K ^c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Brain injuries; Complementary medicine; Rehabilitation; Research; Technology

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BROMAZEPAM; CALCIUM CHANNEL BLOCKING AGENT; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DEXANABINOL; DIAZEPAM; DONEPEZIL; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; MAPROTILINE; MONOAMINE OXIDASE B INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; PHYSOSTIGMINE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TOLCAPONE; UNINDEXED DRUG; VITAMIN;

ALTERNATIVE MEDICINE; ANOREXIA; ASTHENIA; BRAIN INJURY; COGNITION; DIAGNOSTIC IMAGING; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LIVEDO RETICULARIS; LIVER INJURY; MEDICAL RESEARCH; NAUSEA; NEUROPROTECTION; REVIEW; ROBOTICS; SEDATION; SEIZURE; TECHNOLOGY; TELECOMMUNICATION; VERTIGO; VIRTUAL REALITY; VOMITING;

EID: 0037334761     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1053/apmr.2003.50047     Document Type: Review

References (37)

1. Ashwal S, Holshouser BA. New neuroimaging techniques and their potential role in patients with acute brain injury. J Head Trauma Rehabil 1997:12(4):13-35.
2. Castelijns JA, Lycklama a Nijeholt GJ, Mukherji SK. Functional MRI background and clinical applications. Semin Ultrasound CT MR 2000;21:428-33.
3. Maheshwari SR, Fatterpekar GM, Castillo M, Mukherji SK. Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 2000;21:434-51.
4. Novotny E, Ashwal S, Shevell M. Proton magnetic resonance spectroscopy: an emerging technology in pediatric neurology. Pediatr Res 1998;44:1-10.
5. Greenwald BD, Burnett DM, Miller MA. Congenital and acquired brain injury. 1. Brain injury: epidemiology and pathophysiology. Arch Phys Med Rehabil 2003;84 Suppl 1:S3-7.
6. Clifton GL, Miller ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001;344:556-63.
7. Zafonte RD, Lansang R, Giap B. Pathophysiology of traumatic brain injury: an overview of pathways and neuroprotective strategies. Phys Med Rehabil State Art Rev 2001;15:229-44.
8. Verma A. Opportunities for neuroprotection in traumatic brain injury. J Head Trauma Rehabil 2000;15:1149-61.
9. Knoller N, Levi L, Shoshan I, et al. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo controlled, phase II clinical trial. Crit Care Med 2002;30:548-54.
10. Burnett DM, Watanabe TK, Greenwald BD. Congenital and acquired brain injury. 2. Brain injury rehabilitation: medical management. Arch Phys Med Rehabil 2003;84 Suppl 1:S8-11.
11. Cope DN. Psychopharmacological aspects of traumatic brain injury. In: Horn LR, Zasler ND, editors. Medical rehabilitation of traumatic brain injury. Philadelphia: Hanley & Belfus; 1996. p 573-612.
12. Vecht CJ, van Woerkom CA, Teelken AW, Minderhoud JM. Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. A study with and without probenecid administration of their relationship to the state of consciousness after head injury. Arch Neurol 1975;32:792-7.
13. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 1982;217:855-7.
14. Zafonte RD, Lexell J, Cullen N. Possible applications for dopaminergic agents following traumatic brain injury: Part 1. J Head Trauma Rehabil 2000;15:1179-82.
15. Zafonte RD, Lexell J, Cullen N. Possible applications for dopaminergic agents following traumatic brain injury: Part 2. J Head Trauma Rehabil 2001;16:112-6.
16. Van Reekum R, Black SE, Conn D, Clarke D. Cognition-enhancing drugs in dementia: a guide to the near future. Can J Psychiatry 1997;42 Suppl 1:35S-50S.
17. Masanic CA, Bayley MT, van Reekum R, Simard M. Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil 2001;82:896-901.
18. Levin HS, Peters BH, Kalisky Z, et al. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Cent Nerv Syst Trauma 1986;3:333-42.
19. Whitlock JA Jr. Brain injury, cognitive impairment and donepezil. J Head Trauma Rehabil 1999;14:424-7.
20. Levy ML, Cummings JL, Kahn-Rose R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology 1999;45 Suppl 1:15-22.
21. Miller MA, Burnett DM, McElligott JM. Congenital and acquired brain injury. 3. Rehabilitation interventions: cognitive, behavioral, and community reentry. Arch Phys Med Rehabil 2003;84 Suppl 1:S12-7.
22. Elovic E. Use of provigil for underarousal following TBI. J Head Trauma Rehabil 2000;15:1068-71.
23. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
24. Chapman EH, Weintraub RJ, Milburn MA, Pirozzi TO, Woo E. Homeopathic treatment of mild traumatic brain injury: a randomized double-blind, placebo-controlled clinical trial. J Head Trauma Rehabil 1999;14:521-42.
25. Linde K, Melchart D. Randomized controlled trials of individualized homeopathy: a state-of-the-art review. J Altern Complement Med 1998:4:371-88.
26. Linde K, Ramirez G, Mulrow CD, Andrej P, Weidenhammer W, Melchart D. St John's wort for depression - an overview and meta-analysis of randomized clinical trials. BMJ 1996;313:253-8.
27. Eng TR, Maxfield A, Patrick K, Deering MJ, Ratzan SC, Gustafson DH. Access to health information and support: a public highway or a private road? JAMA 1998;280:1371-5.
28. Rizzo AA, Buckwalter JG, Neumann U. Virtual reality and cognitive rehabilitation: a brief review of the future. J Head Trauma Rehabil 1997;12(6):1-15.
29. Zhang L, Abreu BC, Masel B, et al. Virtual reality in the assessment of selected cognitive function after brain injury. Am J Phys Med Rehabil 2001;80:597-604.
30. Gourlay D, Lun KC, Lee YN, Tay J. Virtual reality for relearning daily living skills. Int J Med Inf 2000;60:255-61.
31. Currell R, Urquhart C, Wainwright P, Lewis R. Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Nurs Times 2001;97(35):35.
32. Levine SR, Gorman M. "Telestroke": the application of telemedicine for stroke. Stroke 1999;30:464-9.
33. Shafqat S, Kvedar JC, Guanci MM, Chang Y, Schwamm LH. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke 1999;30:2141-5.
34. Lemaire ED, Boudrias Y, Greene G. Low-bandwidth, Internet-based videoconferencing for physical rehabilitation consultations. J Telemed Telecare 2001;7:82-9.
35. Grimes GJ, Dubois H, Grimes SJ, Greenleaf WJ, Rothenburg S, Cunningham D. Telerehabilitation services using web-based telecommunication. Stud Health Technol Inform 2000:70:113-8.
36. Volpe BT, Krebs HI, Hogan N, Edelstein L, Diels C, Aisen M. A novel approach to stroke rehabilitation: robot-aided sensorimotor stimulation. Neurology 2000;54:1938-44.
37. Burke DT, Leeh SB, Hinman RT, et al. Using talking lights to assist brain injured patients with daily inpatient therapeutic schedule. J Head Trauma Rehabil 2001;16:284-91.